Stay updated with breaking news from Nyse Cvm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cutter & CO Brokerage Inc. decreased its stake in CEL-SCI Co. (NYSE:CVM – Free Report) by 17.6% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 84,711 shares of the company’s stock after selling 18,134 shares during the quarter. Cutter & […]
Cutter & CO Brokerage Inc. cut its position in shares of CEL-SCI Co. (NYSE:CVM – Free Report) by 17.6% during the fourth quarter, Holdings Channel.com reports. The firm owned 84,711 shares of the company’s stock after selling 18,134 shares during the quarter. Cutter & CO Brokerage Inc.’s holdings in CEL-SCI were worth $230,000 at the […]
CEL-SCI (NYSE:CVM – Get Free Report) issued its earnings results on Friday. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02), Yahoo Finance reports. CEL-SCI Price Performance NYSE:CVM opened at $2.75 on Friday. CEL-SCI has a one year low of $1.04 and a one year high […]
StockNews.com began coverage on shares of CEL-SCI (NYSE:CVM – Free Report) in a report published on Thursday morning. The firm issued a sell rating on the stock. CEL-SCI Stock Performance NYSE:CVM opened at $1.19 on Thursday. The company has a current ratio of 1.46, a quick ratio of 1.06 and a debt-to-equity ratio of 0.70. […]
CEL-SCI (NYSE:CVM – Get Free Report) and Outlook Therapeutics (NASDAQ:OTLK – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation and institutional ownership. Volatility and Risk CEL-SCI has a beta of […]